Bacterial Disease Diagnostics Market Growth, Size, Trends, Share, Challenges and Future Outlook
Bacterial Disease Diagnostics Market Size- By Type, By Product, By Technology, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
| Published: Sep-2023 | Report ID: HLCA2357 | Pages: 1 - 221 | Formats*: |
| Category : Healthcare | |||
Bacterial Disease Diagnostics Market Introduction and Overview
According to SPER Market Research, the Global Bacterial Disease Diagnostics Market is estimated to reach USD XX billion by 2033 with a CAGR of 6.5%.
The report includes an in-depth analysis of the Global Bacterial Disease Diagnostics Market, including market size and trends, product mix, distribution channels, and supplier analysis. Various species of bacteria exist. Some of them are contagious, but the majority of them are good for the body. The term "pathogen" refers to any bacterium that causes an infectious disease. To avoid overusing antibiotics and to target the right therapy, a precise identification of bacterial infection is essential. Since the presence of bacteria and inflammation or systemic dysfunction constitute a bacterial infection, more than one diagnostic technique is typically needed to confirm the diagnosis.
- F. Hoffmann-La Roche Ltd. formed a partnership with Janssen Biotech Inc. to increase the scope of its target therapy diagnosis portfolio. It boosts diagnostic technologies and encourages innovation.
- The automated immunoassay system for the VIDAS line, called VIDAS® KUBETM, received a new CE certification from bioMerieux. This will help the food industry and healthcare laboratories quickly service their customers.
Market Opportunities and Challenges
- Opportunities: Increasing Government Initiatives to Improve Healthcare - The World Health Organisation launched the programme Global Health and Peaces in 2021 to address the majority of disease outbreaks and the most pressing health needs of people. The government's goals for preventative healthcare are aligned with the importance of bacterial illness diagnostics for early diagnosis and rapid management of infections.
- Challenges: Lack of Skilled Personnel and Adequate Infrastructure - Advanced diagnostic technologies are not properly supported by established infrastructure in many underdeveloped nations. Additionally, there aren't enough resources—both financial and human—to complete the process successfully.
Market Competitive Landscape
The market exhibits a moderate level of fragmentation, with several major players, including Abbott Laboratories, Accelerate Diagnostics Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Bruker Corp., Danaher Corp., DiaSorin SpA, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., GENERI BIOTECH s.r.o., Great Basin Scientific, Hologic Inc., Meridian Bioscience Inc., Perkin Elmer Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens AG, T2 Biosystems Inc., and Takara Bio Inc., Others. To strengthen their position in the market for infectious disease diagnostics, vendors are employing a variety of techniques, including strategic alliances, collaborations, mergers and acquisitions, geographic growth, and the development of new products and services.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2033 |
| Base year considered | 2022 |
| Forecast period | 2023-2033 |
| Segments covered | By Type, By Product, By Technology, By End User |
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe |
| Companies Covered | Abbott Laboratories, Accelerate Diagnostics Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Bruker Corp., Danaher Corp., DiaSorin SpA, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., GENERI BIOTECH s.r.o., Great Basin Scientific, Hologic Inc., Meridian Bioscience Inc., Perkin Elmer Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens AG, T2 Biosystems Inc., and Takara Bio Inc., Others |
COVID-19 Impact on Global Bacterial Disease Diagnostics Market
The new coronavirus that causes COVID-19 has spurred support from governments around the world for laboratories to expedite testing procedures. Although the pandemic reduced sales across many industries, its application in COVID-19 testing helped the market for infectious illness diagnostics. Regulatory authorities hastened COVID-19 diagnostic products' approval. Major corporations saw the crucial importance of diagnostics and quickly developed tests to reduce the pandemic's consequences. Despite a drop in worldwide instances, the COVID-19 spread has halted, which has resulted in a slower growth rate for the infectious disease diagnostics industry.
Key Target Audience
- Clinical Laboratories
- Environmental and Water Quality Testing Labs
- Food and Beverage Industry
- Health Insurance Providers
- Hospitals and Healthcare Facilities
- Medical Professionals
- Patients and Caregivers
- Pharmaceutical and Biotechnology Companies
- Pharmacies and Pharmacist Practitioners
- Public Health Agencies
- Travel and Immigration Authorities
- Veterinary Clinics and Animal Health Laboratories
- Others
Our in-depth analysis of the Bacterial Disease Diagnostics Market includes the following segments:
| By Type: |
|
| By Product: |
|
| By Technology: |
|
| By End User: |
|
Key Topics Covered in the Report
- Global Bacterial Disease Diagnostics Market Size (FY’2023-FY’2033)
- Overview of Global Bacterial Disease Diagnostics Market
- Segmentation of Global Bacterial Disease Diagnostics Market By Type (Bacterial Skin Infections, Foodborne Infections, Sexually Transmitted Infections)
- Segmentation of Global Bacterial Disease Diagnostics Market By Product (Consumables, Instruments)
- Segmentation of Global Bacterial Disease Diagnostics Market By Technology (DNA Microarray, Immunodiagnostics, Isothermal Nucleic Acid Amplification Technology, Polymerase Chain Reaction)
- Segmentation of Global Bacterial Disease Diagnostics Market By End User (Hospitals, Labs, Research Centres)
- Statistical Snap of Global Bacterial Disease Diagnostics Market
- Expansion Analysis of Global Bacterial Disease Diagnostics Market
- Problems and Obstacles in Global Bacterial Disease Diagnostics Market
- Competitive Landscape in the Global Bacterial Disease Diagnostics Market
- Impact of COVID-19 and Demonetization on Global Bacterial Disease Diagnostics Market
- Details on Current Investment in Global Bacterial Disease Diagnostics Market
- Competitive Analysis of Global Bacterial Disease Diagnostics Market
- Prominent Players in the Global Bacterial Disease Diagnostics Market
- SWOT Analysis of Global Bacterial Disease Diagnostics Market
- Global Bacterial Disease Diagnostics Market Future Outlook and Projections (FY’2023-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPER’s internal database2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Bacterial Disease Diagnostics Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Bacterial Disease Diagnostics Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Bacterial Disease Diagnostics Market
7. Global Bacterial Disease Diagnostics Market, By Type (USD Million)
7.1. Global Bacterial Disease Diagnostics Market Value Share and Forecast, By Type, 2023-20337.2. Bacterial Skin Infections7.3. Foodborne Infections7.4. Sexually Transmitted Infections
8. Global Bacterial Disease Diagnostics Market, By Product (USD Million)
8.1. Global Bacterial Disease Diagnostics Market Value Share and Forecast, By Product, 2023-20338.2. Consumables8.3. Instruments
9. Global Bacterial Disease Diagnostics Market, By Technology (USD Million)
9.1. Global Bacterial Disease Diagnostics Market Value Share and Forecast, By Technology, 2023-20339.2. DNA Microarray9.3. Immunodiagnostics9.4. Isothermal Nucleic Acid Amplification Technology9.5. Polymerase Chain Reaction
10. Global Bacterial Disease Diagnostics Market, By End User (USD Million)
10.1. Global Bacterial Disease Diagnostics Market Value Share and Forecast, By End User, 2023-203310.2. Hospitals10.3. Labs10.4. Research Centres
11. Global Bacterial Disease Diagnostics Market Forecast, 2019-2033 (USD Million)
11.1. Global Bacterial Disease Diagnostics Market Size and Market Share
12. Global Bacterial Disease Diagnostics Market, By Type, 2019-2033 (USD Million)
12.1. Global Bacterial Disease Diagnostics Market Size and Market Share By Type (2019-2026)12.2. Global Bacterial Disease Diagnostics Market Size and Market Share By Type (2027-2033)
13. Global Bacterial Disease Diagnostics Market, By Product, 2019-2033 (USD Million)
13.1. Global Bacterial Disease Diagnostics Market Size and Market Share By Product (2019-2026)13.2. Global Bacterial Disease Diagnostics Market Size and Market Share By Product (2027-2033)
14. Global Bacterial Disease Diagnostics Market, By Technology, 2019-2033 (USD Million)
14.1. Global Bacterial Disease Diagnostics Market Size and Market Share By Technology (2019-2026)14.2. Global Bacterial Disease Diagnostics Market Size and Market Share By Technology (2027-2033)
15. Global Bacterial Disease Diagnostics Market, By End User, 2019-2033 (USD Million)
15.1. Global Bacterial Disease Diagnostics Market Size and Market Share By End User (2019-2026)15.2. Global Bacterial Disease Diagnostics Market Size and Market Share By End User (2027-2033)
16. Global Bacterial Disease Diagnostics Market, By Region, 2019-2033 (USD Million)
16.1. Global Bacterial Disease Diagnostics Market Size and Market Share By Region (2019-2026)16.2. Global Bacterial Disease Diagnostics Market Size and Market Share By Region (2027-2033)16.3. Asia-Pacific
16.3.1. Australia16.3.2. China16.3.3. India16.3.4. Japan16.3.5. South Korea16.3.6. Rest of Asia-Pacific
16.4. Europe
16.4.1. France16.4.2. Germany16.4.3. Italy16.4.4. Spain16.4.5. United Kingdom16.4.6. Rest of Europe
16.5. Middle East and Africa
16.5.1. Kingdom of Saudi Arabia16.5.2. United Arab Emirates16.5.3. Rest of Middle East & Africa
16.6. North America
16.6.1. Canada16.6.2. Mexico16.6.3. United States
16.7. Latin America
16.7.1. Argentina16.7.2. Brazil16.7.3. Rest of Latin America
17. Company Profile
17.1. Abbott Laboratories
17.1.1. Company details17.1.2. Financial outlook17.1.3. Product summary17.1.4. Recent developments
17.2. Accelerate Diagnostics Inc.
17.2.1. Company details17.2.2. Financial outlook17.2.3. Product summary17.2.4. Recent developments
17.3. Becton Dickinson and Co.
17.3.1. Company details17.3.2. Financial outlook17.3.3. Product summary17.3.4. Recent developments
17.4. Bio Rad Laboratories Inc.
17.4.1. Company details17.4.2. Financial outlook17.4.3. Product summary17.4.4. Recent developments
17.5. bioMerieux SA
17.5.1. Company details17.5.2. Financial outlook17.5.3. Product summary17.5.4. Recent developments
17.6. Bruker Corp.
17.6.1. Company details17.6.2. Financial outlook17.6.3. Product summary17.6.4. Recent developments
17.7. Danaher Corp
17.7.1. Company details17.7.2. Financial outlook17.7.3. Product summary17.7.4. Recent developments
17.8. DiaSorin SpA
17.8.1. Company details17.8.2. Financial outlook17.8.3. Product summary17.8.4. Recent developments
17.9. EKF Diagnostics Holdings Plc
17.9.1. Company details17.9.2. Financial outlook17.9.3. Product summary17.9.4. Recent developments
17.10. F. Hoffmann La Roche Ltd.
17.10.1. Company details17.10.2. Financial outlook17.10.3. Product summary17.10.4. Recent developments
17.11. GENERI BIOTECH s.r.o.
17.11.1. Company details17.11.2. Financial outlook17.11.3. Product summary17.11.4. Recent developments
17.12. Great Basin Scientific
17.12.1. Company details17.12.2. Financial outlook17.12.3. Product summary17.12.4. Recent developments
17.13. Hologic Inc.
17.13.1. Company details17.13.2. Financial outlook17.13.3. Product summary17.13.4. Recent developments
17.14. Meridian Bioscience Inc.
17.14.1. Company details17.14.2. Financial outlook17.14.3. Product summary17.14.4. Recent developments
17.15. Perkin Elmer Inc.
17.15.1. Company details17.15.2. Financial outlook17.15.3. Product summary17.15.4. Recent developments
17.16. QIAGEN NV
17.16.1. Company details17.16.2. Financial outlook17.16.3. Product summary17.16.4. Recent developments
17.17. Quest Diagnostics Inc.
17.17.1. Company details17.17.2. Financial outlook17.17.3. Product summary17.17.4. Recent developments
17.18. Siemens AG
17.18.1. Company details17.18.2. Financial outlook17.18.3. Product summary17.18.4. Recent developments
17.19. T2 Biosystems Inc.
17.19.1. Company details17.19.2. Financial outlook17.19.3. Product summary17.19.4. Recent developments
17.20. Takara Bio Inc.
17.20.1. Company details17.20.2. Financial outlook17.20.3. Product summary17.20.4. Recent developments
17.21. Others
18. List of Abbreviations
19. Reference Links
20. Conclusion
21. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Bacterial Disease Diagnostics Market grew in market size from 2022. The Market is expected to reach USD XX billion by 2033, at a CAGR of 6.5% during the forecast period.
Bacterial Disease Diagnostics Market CAGR of 6.5% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Bacterial Disease Diagnostics Market size is USD XX billion from 2023 to 2033.
Bacterial Disease Diagnostics Market Segment is covered By Type, By Product, By Technology, By End User.
The North America is anticipated to have the highest market share in the Bacterial Disease Diagnostics Market .
The key players in the market include Companies Covered Abbott Laboratories, Accelerate Diagnostics Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Bruker Corp., Danaher Corp., DiaSorin SpA.
The term "pathogen" refers to any bacterium that causes an infectious disease. To avoid overusing antibiotics and to target the right therapy, a precise identification of bacterial infection is essential.
Bacterial Disease Diagnostics Market is projected to reach USD XX billion by 2033, growing at a CAGR of 6.5% during the forecast period.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
